Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Recruiting 11 Completed 11 Active not recruiting 9 Unknown 3 Withdrawn 2 Terminated 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Biliary Tract Cancer(BTC) 1

Interventions

Carboplatin 79 Cisplatin 74 Bevacizumab 62 Radiotherapy 59 Drug Therapy 57 Capecitabine 57 Oxaliplatin 56 tislelizumab 54 toripalimab 45 Paclitaxel 44 Gemcitabine 43 pembrolizumab 40 anlotinib 40 Specimen Handling 39 sintilimab 37 Cyclophosphamide 34 130-nm albumin-bound paclitaxel 34 Injections 30 Pemetrexed 28 camrelizumab 26 Surgical Procedures, Operative 26 Magnetic Resonance Spectroscopy 25 lenvatinib 24 apatinib 23 Docetaxel 23 Etoposide 22 S 1 (combination) 21 Fluorouracil 21 Immune Checkpoint Inhibitors 20 Biopsy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Not yet recruiting × relatlimab × Clear all

NCT07369791 2026-01-28

NOBLE

National Health Research Institutes, Taiwan

Phase 2 Not yet recruiting

Gastrointestinal

Advanced Biliary Tract Cancer(BTC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡